Author

Robert Fox

Observed name: Fox, Robert

Institutions: Cleveland Clinic, Lou Ruvo Brain Institute

Observed institutions: Cleveland Clinic, Lou Ruvo Brain Institute

OpenAlex ID: A5138146827

Association of object mnemonic discrimination deficit with age and AD biomarkers in older adults

2026 · Zhengshi Yang, Xiaowei Zhuang, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Blood Levels of Immune Cells, Immunoglobulins, and Platelets in the Phase Three HERCULES and GEMINI Trials of Tolebrutinib in Non-relapsing Secondary Progressive Multiple Sclerosis and Relapsing Multiple Sclerosis (P9-19.001)

2026 · Celia Oreja Guevara, Amit Bar-Or, et al. · Neurology

Efficacy and Safety of Tolebrutinib Versus Placebo in Primary Progressive Multiple Sclerosis: Results from the Phase Three PERSEUS Trial (PL6.003)

2026 · Robert Fox, Amit Bar-Or, et al. · Neurology

Subgroup Analysis of the Phase Three Tolebrutinib HERCULES Trial: Disability Accumulation Outcomes in North American Participants (P9-19.003)

2026 · Patricia Coyle, Amit Bar-Or, et al. · Neurology

Progression to Wheelchair in Secondary Progressive Multiple Sclerosis and Impact of Siponimod: Post Hoc Analyses From the EXPAND Study

2026 · Patrick Vermersch, Sophie Arnould, et al. · European Journal of Neurology

Works count: 6

Citation count:

H-index:

I10-index: